Showing 971-980 of 8860 results for "".
SCALE 2024: Dr. Linda Stein Gold on Benzyne Release From Benzyl Peroxide
https://practicaldermatology.com/conferences/scale-2024/scale-2024-dr-linda-stein-gold-benzyne-release-from-benzyl-peroxide/26373/Linda Stein Gold, MD, discusses the new information on benzyl peroxide and its implications at Music City SCALE.Analysis Evaluates Risks of Cardiovascular Events Among Biologics for Psoriatic Diseases
https://practicaldermatology.com/series/dermwire-tv/analysis-evaluates-risks-of-cardiovascular-events-among-biologics-for-psoriatic-diseases/32412/In this week's DermwireTV, a new analysis evaluates the risks of major adverse cardiovascular events among patients treated with biologics for psoriatic diseases; a phase 3 clinical trial examines the use of nemolizumab in adults with prurigo nodularis; and the president of Journey Medical discussesSDPA: Medical Director Dr. Hilary Baldwin on Conference Planning Process
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-medical-director-dr-hilary-baldwin-conference-planning-process/29507/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with conference medical director Hilary Baldwin, MD. Dr. Baldwin shares insights on the process of planning SDPA.SDPA: Sara Wilchowski Talks About Transitioning to Industry and Understanding How Nutraceuticals Can Help Patients
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-sara-wilchowski-talks-about-transitioning-to-industry-and-understanding-how-nutraceuticals-can-help-patients/29513/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with Sara Wilchowski, DMSc, MPAS, PA-C. Wilchowski is currently a senior medical science liaison and joined a panel of MSLs to discuss the ins and outs of transitioning to industry. Following the panel, she gave a lBurnout; Qwo Campaign; Differin, Cetaphil Programs; DermTech Data: DermWireTV
https://practicaldermatology.com/topics/skin-cancer-photoprotection/burnout-qwo-campaign-differin-cetaphil-programs-dermtech-data-dermwiretv/20063/The Dr. Lorna Breen Health Care Provider Protection Act is headed to the president, as the latest Medscape Physician Burnout and Depression Report shows more than half of physicians experiencing burnout say it has a strong or severe impact on their life. Differin marks Retinoid Awareness Week. CetapKeeping SEO a Priority When Managing Your Budget during COVID
https://practicaldermatology.com/topics/practice-management/keeping-seo-a-priority-when-managing-your-budget-during-covid/19873/With rising expenses and shrinking budgets, many dermatology practices are putting SEO on pause. Is that a wise move? Watch the latest video from Ekwa Marketing to find out.Possible Reasons for Low Search Rankings of your Dermatology Practice Website
https://practicaldermatology.com/topics/practice-management/possible-reasons-for-low-search-rankings-of-your-dermatology-practice-website/19626/Improving the search engine ranking of your dermatology practice website helps you expand your outreach rapidly. This Ekwa Marketing video contains information related to the five most important aspects related to your website that you should audit to help improve its search engine rankings.Dr. Simpson Highlights Potentially Remittive Anti-OX40s at Maui Derm
https://practicaldermatology.com/programs/practical-dermatology/dr-simpson-highlights-potentially-remittive-anti-ox40s-at-maui-derm/32920/Two anti-OX40 drugs in the pipeline may have remittive properties for atopic dermatitis, according to Eric Simpson, MD.Science of Skincare Summit 2024:Presentation of Disease in Patients with Skin of Color
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-presentation-of-disease-in-patients-with-skin-of-color/29456/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Nada Elbuluk, MD, a dermatologist at the University of Southern California specializing in pigmentary disorders and skin of color, about some of the challenges of diagnosing disease such as erythema in patients with skin of colorDermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologies with Avit